Skinvisible, Inc. (SKVI) stock
SKVIOTCPharmaceutical PreparationsFiscal year ends December 31
$0.16+0.00 (+0.06%)
Close on Oct 19, 2026Market cap $843.54KP/E –Yield –
Skinvisible profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Skinvisible's profit margin for the twelve months ending Jun 30, 2026 was -5156.6%. For fiscal 2025 it was -5320.2%, against -2828.3% the year before. The highest annual figure on record is 228.3% in fiscal 2018.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -5320.2% | −2491.9 |
| FY2024 | Dec 31, 2024 | -2828.3% | +9083.9 |
| FY2023 | Dec 31, 2023 | -11912.2% | −11473.6 |
| FY2022 | Dec 31, 2022 | -438.6% | −276.9 |
| FY2021 | Dec 31, 2021 | -161.7% | +786.7 |
| FY2020 | Dec 31, 2020 | -948.4% | +3097.9 |
| FY2019 | Dec 31, 2019 | -4046.3% | −4274.7 |
| FY2018 | Dec 31, 2018 | 228.3% | +518.8 |
| FY2017 | Dec 31, 2017 | -290.4% | +1593.0 |
| FY2016 | Dec 31, 2016 | -1883.4% | −743.8 |
| FY2015 | Dec 31, 2015 | -1139.6% | +2367.7 |
| FY2014 | Dec 31, 2014 | -3507.3% | −1493.1 |
| FY2013 | Dec 31, 2013 | -2014.3% | −1476.9 |
| FY2012 | Dec 31, 2012 | -537.3% | +217.7 |
| FY2011 | Dec 31, 2011 | -755.0% | −286.8 |
| FY2010 | Dec 31, 2010 | -468.2% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -5110.7% | +377.9 |
| Q1 FY2026 | Mar 31, 2026 | -5343.7% | +276.4 |
| Q4 FY2025 | Dec 31, 2025 | -5167.1% | −11462.6 |
| Q3 FY2025 | Sep 30, 2025 | -5004.9% | +727.2 |
| Q2 FY2025 | Jun 30, 2025 | -5488.5% | +580.4 |
| Q1 FY2025 | Mar 31, 2025 | -5620.1% | +187.3 |
| Q4 FY2024 | Dec 31, 2024 | 6295.4% | +12371.2 |
| Q3 FY2024 | Sep 30, 2024 | -5732.1% | +18.3 |
| Q2 FY2024 | Jun 30, 2024 | -6069.0% | −547.5 |
| Q1 FY2024 | Mar 31, 2024 | -5807.4% | +24493.7 |
| Q4 FY2023 | Dec 31, 2023 | -6075.8% | +1935.7 |
| Q3 FY2023 | Sep 30, 2023 | -5750.4% | −1262.7 |
| Q2 FY2023 | Jun 30, 2023 | -5521.5% | −5456.1 |
| Q1 FY2023 | Mar 31, 2023 | -30301.1% | −30118.6 |
| Q4 FY2022 | Dec 31, 2022 | -8011.5% | −7918.0 |
| Q3 FY2022 | Sep 30, 2022 | -4487.6% | −873.8 |
| Q4 FY2021 | Dec 31, 2021 | -65.4% | +159.7 |
| Q3 FY2021 | Sep 30, 2021 | -182.5% | +9613.3 |
| Q2 FY2021 | Jun 30, 2021 | -93.5% | +3382.0 |
| Q1 FY2021 | Mar 31, 2021 | -3613.8% | −934.5 |
| Q4 FY2020 | Dec 31, 2020 | -225.1% | +3736.0 |
| Q3 FY2020 | Sep 30, 2020 | -9795.8% | −6708.2 |
| Q2 FY2020 | Jun 30, 2020 | -3475.5% | +1145.4 |
| Q1 FY2020 | Mar 31, 2020 | -2679.3% | +1421.3 |
| Q4 FY2019 | Dec 31, 2019 | -3961.1% | −2568.6 |
| Q3 FY2019 | Sep 30, 2019 | -3087.6% | −6493.8 |
| Q2 FY2019 | Jun 30, 2019 | -4620.8% | −2840.8 |
| Q1 FY2019 | Mar 31, 2019 | -4100.6% | −4718.1 |
| Q4 FY2018 | Dec 31, 2018 | -1392.5% | −1368.5 |
| Q3 FY2018 | Sep 30, 2018 | 3406.2% | +4305.3 |
| Q2 FY2018 | Jun 30, 2018 | -1780.0% | −169.6 |
| Q1 FY2018 | Mar 31, 2018 | 617.5% | +4445.7 |
| Q4 FY2017 | Dec 31, 2017 | -24.0% | +1823.6 |
| Q3 FY2017 | Sep 30, 2017 | -899.1% | +1980.6 |
| Q2 FY2017 | Jun 30, 2017 | -1610.4% | −393.2 |
| Q1 FY2017 | Mar 31, 2017 | -3828.2% | – |
| Q4 FY2016 | Dec 31, 2016 | -1847.6% | – |
| Q3 FY2016 | Sep 30, 2016 | -2879.7% | – |
| Q2 FY2016 | Jun 30, 2016 | -1217.2% | – |
See a number that looks wrong?